Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,572,000
-$11,753,000 QoQ
Shares Held
700,000
-60.0% QoQ
Ownership
0.628%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#33
of 207 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREAT POINT PARTNERS LLC holds $16,415,268 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #1 (76.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
700,000 | $12,572,000 | |
| 2 | SCYX |
Scynexis Inc
|
944,292 | $3,843,268 |
All Filings in AMLX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,572,000 | 700,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,325,000 | 1,750,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,140,000 | 1,750,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,103,000 | 1,700,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,820,000 | 2,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,414,465 | 1,811,996 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $20,896,908 | 968,795 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,996,545 | 783,795 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,020,500 | 190,000 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||